The role of inflammation in carcinogenesis in UC CRC is widely known, but our study suggests an association of inflammation with sporadic CRC pathogenesis as well, irrespective of some known drivers such as KRAS mutation and MSI. This evidence concerns the gene KRAS and colorectal carcinoma.